New 13D21
New 13G61
Stated intents0
The week of 2025-09-29, 21 holders filed a new Schedule 13D and 61 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-10-02 | Grande Group Ltd | Grande Holding Limited | 76.33% | SCHEDULE 13D |
| 2025-10-02 | Vocodia Holdings Corp | Paul Taylor | 28.78% | SCHEDULE 13D |
| 2025-09-30 | Tiptree Inc. | Barnes Michael Gene | 27.35% | SCHEDULE 13D |
| 2025-09-30 | Bonk, Inc. | Lucky Dog Holdings | 19.99% | SCHEDULE 13D |
| 2025-10-02 | Solana Co | Fusion Summer Limited | 17% | SCHEDULE 13D |
| 2025-10-02 | Global Business Travel Group, Inc. | Qatar Investment Authority | 16.6% | SCHEDULE 13D |
| 2025-10-01 | Kodiak AI, Inc. | Burnette Donald L. | 15.1% | SCHEDULE 13D |
| 2025-09-30 | Youlife Group Inc. | Yunlei Wang | 14.7% | SCHEDULE 13D |
| 2025-10-01 | Mgt Capital Investments, Inc. | Michael G. Onghai | 11.5% | SCHEDULE 13D |
| 2025-10-02 | Drugs Made In America Acquisition II Corp. | Drugs Made In America Acquisition II LLC | 10.2% | SCHEDULE 13D |
| 2025-09-30 | Brera Holdings PLC | RBCH Ltd | 9.99% | SCHEDULE 13D |
| 2025-09-29 | Electronic Arts Inc. | Public Investment Fund | 9.9% | SCHEDULE 13D |
| 2025-09-30 | CollPlant Biotechnologies Ltd | Loewenbaum Lilian S. | 9.9% | SCHEDULE 13D |
| 2025-10-03 | SAB Biotherapeutics, Inc. | RA Capital Management, L.P. | 9.9% | SCHEDULE 13D |
| 2025-09-30 | Tiptree Inc. | Inayatullah Arif | 8.97% | SCHEDULE 13D |
| 2025-10-02 | Datavault Ai Inc. | Scilex Holding Company | 8.03% | SCHEDULE 13D |
| 2025-10-01 | Kodiak AI, Inc. | Battery Ventures XII, L.P. | 6.3% | SCHEDULE 13D |
| 2025-09-30 | TurnOnGreen, Inc. | Caspi Steven | 6.2% | SCHEDULE 13D |
| 2025-10-03 | 89bio, Inc. | Adage Capital Management, L.P. | 6.13% | SCHEDULE 13D |
| 2025-10-03 | Waystar Holding Corp | Advent International, L.P. | 5.8% | SCHEDULE 13D |
| 2025-10-01 | Acadia Healthcare Company, Inc. | Khrom Investments Fund, LP | 5.5% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-09-29 | 3 E Network Technology Group Ltd | Law Shu Sang Joseph | 53.7% | SCHEDULE 13G |
| 2025-10-03 | Anfield Energy Inc. | Uranium Energy Corp | 37% | SCHEDULE 13G |
| 2025-10-03 | Boxabl Inc. | Galiano Tiramani | 26% | SCHEDULE 13G |
| 2025-09-29 | Brenmiller Energy Ltd. | Alpha Capital Anstalt | 15.3% | SCHEDULE 13G |
| 2025-10-01 | CAMPBELL'S Co | Catherine D. Malone, as Trustee of the Mary Alice Dorrance Malone Revocable Trust | 13.4% | SCHEDULE 13G |
| 2025-10-01 | Concorde International Group Ltd | SoftBank Robotics Singapore Pte Ltd. | 11.39% | SCHEDULE 13G |
| 2025-10-02 | Kodiak Gas Services Inc | BlackRock, Inc. | 10.9% | SCHEDULE 13G |
| 2025-10-03 | D.R. Horton, Inc. | Capital World Investors | 10.2% | SCHEDULE 13G |
| 2025-09-30 | RYTHM, Inc. | Double Or Nothing LLC | 10% | SCHEDULE 13G |
| 2025-09-29 | WORK Medical Technology Group LTD | Bigger Capital Fund L P | 9.99% | SCHEDULE 13G |
| 2025-10-01 | Forum Markets Inc | Cyber Citadel | 9.99% | SCHEDULE 13G |
| 2025-10-02 | Solana Co | Solana Rocket Holdings Limited | 9.99% | SCHEDULE 13G |
| 2025-10-03 | WORK Medical Technology Group LTD | L1 Capital Global Opportunities Master Fund, Ltd. | 9.99% | SCHEDULE 13G |
| 2025-10-03 | KALA BIO, Inc. | Baker Bros. Advisors LP | 9.99% | SCHEDULE 13G |
| 2025-10-03 | X4 Pharmaceuticals, Inc. | Coastlands Capital LP | 9.99% | SCHEDULE 13G |
| 2025-10-03 | SAB Biotherapeutics, Inc. | Vivo Opportunity Fund Holdings, L.P. | 9.99% | SCHEDULE 13G |
| 2025-09-29 | PMGC Holdings Inc. | Streeterville Capital LLC | 9.9% | SCHEDULE 13G |
| 2025-10-01 | VSee Health, Inc. | Dominion Capital LLC | 9.9% | SCHEDULE 13G |
| 2025-10-02 | Fitell Corporation | ATW Digital Asset Opportunities IX LLC | 9.9% | SCHEDULE 13G |
| 2025-10-03 | SAB Biotherapeutics, Inc. | Commodore Capital LP | 9.9% | SCHEDULE 13G |
| 2025-10-03 | Lotus Technology Inc. | JAK Opportunities XXV LLC | 9.9% | SCHEDULE 13G |
| 2025-10-01 | Kodiak AI, Inc. | Paz Eshel Living Trust | 9.4% | SCHEDULE 13G |
| 2025-10-02 | Tenax Therapeutics, Inc. | Raymond Debbane | 9.4% | SCHEDULE 13G |
| 2025-10-02 | Black Rock Coffee Bar, Inc. | Gilder Gagnon Howe & Co LLC | 9.2% | SCHEDULE 13G |
| 2025-10-03 | Alpha Cognition Inc. | Opaleye Management Inc. | 8.97% | SCHEDULE 13G |
| 2025-10-02 | BlackRock Multi-Sector Income Trust | Sit Investment Associates, Inc. | 8.9% | SCHEDULE 13G |
| 2025-10-02 | Forum Markets Inc | Electric Capital Partners Frontier Master Fund, LP | 8.6% | SCHEDULE 13G |
| 2025-10-03 | Liveperson Inc | Linden Advisors LP | 8.5% | SCHEDULE 13G |
| 2025-10-02 | Flaherty & Crumrine Preferred & Income Fund Inc | Sit Investment Associates, Inc. | 8.4% | SCHEDULE 13G |
| 2025-10-02 | Lakeland Industries Inc | Lempel Brian David | 8.3% | SCHEDULE 13G |
| 2025-10-01 | Boxlight Corp | L1 Capital Global Opportunities Master Fund, Ltd. | 7.8% | SCHEDULE 13G |
| 2025-10-03 | Monte Rosa Therapeutics, Inc. | Adam Goulburn | 7.7% | SCHEDULE 13G |
| 2025-10-03 | GigCapital7 Corp. | Tenor Capital Management Company, L.P. | 7.5% | SCHEDULE 13G |
| 2025-09-29 | Fusion Fuel Green PLC | Roxy Capital Corp | 7.31% | SCHEDULE 13G |
| 2025-09-30 | Kodiak AI, Inc. | Shigeki Saitoh | 7.2% | SCHEDULE 13G |
| 2025-10-03 | Silo Pharma, Inc. | SEG Opportunity Fund, LLC | 7.1% | SCHEDULE 13G |
| 2025-10-01 | Emmis Acquisition Corp. | Linden Capital L.P. | 6.3% | SCHEDULE 13G |
| 2025-10-03 | Enveric Biosciences, Inc. | AdvisorShares Trust | 6.27% | SCHEDULE 13G |
| 2025-10-01 | Emmis Acquisition Corp. | Harraden Circle Investments, LLC | 6% | SCHEDULE 13G |
| 2025-10-02 | Invesco Bond Fund | Sit Investment Associates, Inc. | 5.9% | SCHEDULE 13G |
| 2025-10-02 | Willow Lane Acquisition Corp. | Hiddenite Capital Partners LP | 5.9% | SCHEDULE 13G |
| 2025-09-29 | Theratechnologies Inc. | Summer Road LLC | 5.84% | SCHEDULE 13G |
| 2025-10-01 | bioAffinity Technologies, Inc. | Bigger Michael | 5.79% | SCHEDULE 13G |
| 2025-10-01 | Kodiak AI, Inc. | Soros Fund Management LLC | 5.7% | SCHEDULE 13G |
| 2025-10-03 | Immuneering Corp | HBM Healthcare Investments (Cayman) Ltd. | 5.7% | SCHEDULE 13G |
| 2025-10-02 | Rezolve AI plc | Kenneth Griffin | 5.5% | SCHEDULE 13G |
| 2025-09-30 | Terrestrial Energy Inc. | Kenneth Griffin | 5.4% | SCHEDULE 13G |
| 2025-10-02 | The Gabelli Healthcare & WellnessRx Trust | Sit Investment Associates, Inc. | 5.4% | SCHEDULE 13G |
| 2025-10-03 | dMY Squared Technology Group, Inc. | Shay Capital LLC | 5.4% | SCHEDULE 13G |
| 2025-09-29 | Reviva Pharmaceuticals Holdi | 683 Capital Management, LLC | 5.36% | SCHEDULE 13G |
| 2025-09-29 | Potbelly Corporation | Glazer Capital, LLC | 5.31% | SCHEDULE 13G |
| 2025-09-30 | Abeona Therapeutics Inc. | James Russell Revocable Trust | 5.3% | SCHEDULE 13G |
| 2025-10-01 | Bloom Energy Corp | D. E. Shaw & Co., L.P. | 5.3% | SCHEDULE 13G |
| 2025-10-03 | Village Farms International, Inc. | AdvisorShares Trust | 5.29% | SCHEDULE 13G |
| 2025-10-01 | SUI Group Holdings Ltd. | MMCAP International Inc. SPC | 5.2% | SCHEDULE 13G |
| 2025-10-01 | BioXcel Therapeutics, Inc. | Integrated Core Strategies (US) LLC | 5.2% | SCHEDULE 13G |
| 2025-10-02 | Blackrock Munivest Fund Ii, Inc. | Sit Investment Associates, Inc. | 5.2% | SCHEDULE 13G |
| 2025-10-03 | PepGen Inc. | Viking Global Investors LP | 5.1% | SCHEDULE 13G |
| 2025-10-03 | Sportsman'S Warehouse Holdings, Inc. | Leon Zaltzman | 5.04% | SCHEDULE 13G |
| 2025-09-29 | Guidewire Software, Inc. | Linonia Partners Fund LP | 5% | SCHEDULE 13G |
| 2025-10-03 | Odysseus (Cayman) Ltd | Tenor Capital Management Company, L.P. | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Download this data (CSV)82 rows, with sources
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.